BioMimetic Therapeutics, Inc. (NASDAQ:BMTI.DL)
CAPS Rating:
The Company develops and commercializes bio-active drug-device combination products for the healing of musculoskeletal injuries and diseases, including periodontal, orthopedic, spine and sports injury applications.
RSS Headlines
Fool UK
Recs
disruptive technology will turbocharge this stock